Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2016

12.07.2016 | Gynecologic Oncology

Female breast cancer burden was increasing during the 40 years in Hebei Province, China: a population-based study

verfasst von: Jin Shi, Di Liang, Jing Jin, Liqun Wang, Yutong He

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of our study was to estimate the female breast cancer burden and mortality trends in Hebei Province, China.

Methods

Eight population-based cancer registries in Hebei Province submitted cancer data to the Hebei Provincial cancer Registry Centre. All data were reviewed for quality and compiled for cancer statistics in 2011. The pooled data were stratified by area (urban/rural) and age group (0–4, 5–9, …, 80+ years). Incidence and mortality rates were calculated and expressed per 100,000 persons. Proportions and ranks for breast cancer were calculated. Mortality data from 1973 to 1975, 1990 to 1992, and 2004 to 2005 were extracted from the national death surveys. Mortality and incidence data from Cixian and Shexian were obtained from population-based cancer registries in each county.

Results

The estimated numbers of newly diagnosed breast cancer cases and deaths from 2010 to 2011 were 26,028 and 5472, respectively. The CIR was 36.6/100,000. The ASIRW was 27.7/100,000, ranking the highest among all female cancers. The CMR was 7.7/100,000, and the ASMRW was 6.0/100,000, ranking fifth in female mortality. The ASMRW displayed an increasing trend in Hebei Province from 1973–1975 to 2010–2011, with a 53.7 % increase. In Cixian, the incidence rate increased with an annual percentage change (APC) of 7.7 %, and the mortality rate increased with an APC of 3.8 % from 1988 to 2011. Similar trends were observed for the incidence and mortality rates in Shexian, with APCs of 20.1 % and 11.0 %, respectively, from 2000 to 2011.

Conclusion

Hebei Province experienced a heavy burden of breast cancer. The mortality rates increased during the past 40 years and the incidence and mortality trends may continue to increase in the next few years.
Literatur
1.
Zurück zum Zitat von Au A, Weiler U, Stefanovic S, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C (2016) Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study. Arch Gynecol Obstet 294(1):1445–1452. doi:10.1007/s00404-015-3938-0 von Au A, Weiler U, Stefanovic S, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C (2016) Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study. Arch Gynecol Obstet 294(1):1445–1452. doi:10.​1007/​s00404-015-3938-0
7.
Zurück zum Zitat Office for Cancer Prevention, Control, Ministry of Health, P.R. China (1980) Malignant tumor mortality survey report, 1st edn. People’s Medical Publishing House, Beijing Office for Cancer Prevention, Control, Ministry of Health, P.R. China (1980) Malignant tumor mortality survey report, 1st edn. People’s Medical Publishing House, Beijing
8.
Zurück zum Zitat Zhang GS, He YT, Hou J (1998) The geographical distribution of cancer death in Hebei province 1990–1992. Chin Cancer 7:5–21 Zhang GS, He YT, Hou J (1998) The geographical distribution of cancer death in Hebei province 1990–1992. Chin Cancer 7:5–21
9.
Zurück zum Zitat Office for Cancer Prevention, Control, Ministry of Health, P.R. China (2007) Malignant tumor mortality survey report (2004–2005), 1st edn. People’s Medical Publishing House, Beijing Office for Cancer Prevention, Control, Ministry of Health, P.R. China (2007) Malignant tumor mortality survey report (2004–2005), 1st edn. People’s Medical Publishing House, Beijing
10.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay L, Teppo L, Thomas DB (2005) Cancer incidence in five continents CI5 VIII. IARC Scientific Publications No 155.WHO/IARC, Lyon Parkin DM, Whelan SL, Ferlay L, Teppo L, Thomas DB (2005) Cancer incidence in five continents CI5 VIII. IARC Scientific Publications No 155.WHO/IARC, Lyon
11.
Zurück zum Zitat Forman D, Bray F, Brewster DH (2013) Cancer incidence in five continents, vol X. IARC, Lyon Forman D, Bray F, Brewster DH (2013) Cancer incidence in five continents, vol X. IARC, Lyon
12.
Zurück zum Zitat Felay J, Burkhard C, Whelan S (2005) Check and conversion programs for cancer registries. IARC technical report No. 42 Felay J, Burkhard C, Whelan S (2005) Check and conversion programs for cancer registries. IARC technical report No. 42
13.
Zurück zum Zitat Kim HJ, Fay MP, Feuer EJ (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–5114CrossRefPubMed Kim HJ, Fay MP, Feuer EJ (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–5114CrossRefPubMed
15.
Zurück zum Zitat Yu HL, Kolovos A, Christakos G, Chen J-C, Warmerdam S (2007) Interactive spatiotemporal modelling of health systems: the SEKS-GUI framework. Stoch Env Res Risk Ass 21(5):555–572CrossRef Yu HL, Kolovos A, Christakos G, Chen J-C, Warmerdam S (2007) Interactive spatiotemporal modelling of health systems: the SEKS-GUI framework. Stoch Env Res Risk Ass 21(5):555–572CrossRef
16.
Zurück zum Zitat Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19(8):1893–1907. doi:10.1158/1055-9965 CrossRef Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19(8):1893–1907. doi:10.​1158/​1055-9965 CrossRef
18.
Zurück zum Zitat Zheng Y, Wu CX, Wu F (2011) Status and trends of breast cancer mortality in Chinese females. Zhonghua Yu Fang Yi Xue Za Zhi 45(2):150–154PubMed Zheng Y, Wu CX, Wu F (2011) Status and trends of breast cancer mortality in Chinese females. Zhonghua Yu Fang Yi Xue Za Zhi 45(2):150–154PubMed
19.
Zurück zum Zitat Song QK, Li J, Huang R, Fan JH, Zheng RS, Zhang BN (2014) Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European Union. Asian Pac J Cancer P 15(22):10021–10025CrossRef Song QK, Li J, Huang R, Fan JH, Zheng RS, Zhang BN (2014) Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European Union. Asian Pac J Cancer P 15(22):10021–10025CrossRef
20.
Zurück zum Zitat Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, Zheng S, Zhang B, Yang HJ, Xie XM, Tang ZH, Li H, Li JY, He JJ, Qiao YL (2011) A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11:364. doi:10.1186/1471-2407-11-364 CrossRefPubMedPubMedCentral Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, Zheng S, Zhang B, Yang HJ, Xie XM, Tang ZH, Li H, Li JY, He JJ, Qiao YL (2011) A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11:364. doi:10.​1186/​1471-2407-11-364 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117(2):409–416. doi:10.1007/s10549-008-0303-z CrossRefPubMed Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117(2):409–416. doi:10.​1007/​s10549-008-0303-z CrossRefPubMed
22.
Zurück zum Zitat Jueckstock J, Kasch F, Jaeger B, Schramm A, Janni W, Scholz C (2015) Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis. Arch Gynecol Obstet 292(5):1101–1107. doi:10.1007/s00404-015-3728-8 CrossRefPubMed Jueckstock J, Kasch F, Jaeger B, Schramm A, Janni W, Scholz C (2015) Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis. Arch Gynecol Obstet 292(5):1101–1107. doi:10.​1007/​s00404-015-3728-8 CrossRefPubMed
23.
Zurück zum Zitat Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6(6):229–239CrossRefPubMedPubMedCentral Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6(6):229–239CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Namiranian N, Moradi-Lakeh M, Razavi-Ratki SK, Doayie M, Nojomi M (2014) Risk factors of breast cancer in the Eastern Mediterranean Region: a systematic review and meta-analysis. Asian Pac J Cancer P 15(21):9535–9541CrossRef Namiranian N, Moradi-Lakeh M, Razavi-Ratki SK, Doayie M, Nojomi M (2014) Risk factors of breast cancer in the Eastern Mediterranean Region: a systematic review and meta-analysis. Asian Pac J Cancer P 15(21):9535–9541CrossRef
26.
Zurück zum Zitat Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA (2004) Socioeconomic risk factors for breast cancer: distinguishing individual and community-level effects. Epidemiology 15(4):442–450CrossRefPubMed Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA (2004) Socioeconomic risk factors for breast cancer: distinguishing individual and community-level effects. Epidemiology 15(4):442–450CrossRefPubMed
27.
Zurück zum Zitat Zhang P (2013) The report of national physique monitor in Hebei province, 2010. Hebei province, China Zhang P (2013) The report of national physique monitor in Hebei province, 2010. Hebei province, China
28.
Zurück zum Zitat Guo L, Li N, Wang G, Su K, Li F, Yang L (2014) Body mass index and cancer incidence: a prospective cohort study in northern China. Zhonghua Liu Xing Bing Xue Za Zhi 35(3):231–236PubMed Guo L, Li N, Wang G, Su K, Li F, Yang L (2014) Body mass index and cancer incidence: a prospective cohort study in northern China. Zhonghua Liu Xing Bing Xue Za Zhi 35(3):231–236PubMed
29.
Zurück zum Zitat Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, Ruan ZX, Su Y, Gu K, Lu W, Zheng W (2011) Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol 174(6):661–671. doi:10.1093/aje/kwr145 CrossRefPubMedPubMedCentral Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, Ruan ZX, Su Y, Gu K, Lu W, Zheng W (2011) Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol 174(6):661–671. doi:10.​1093/​aje/​kwr145 CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Schwab FD, Kilic N, Huang DJ, Schmid SM, Vetter M, Schötzau A, Güth U (2015) Personal or first-degree family breast cancer history: which has higher impact on tumor detection and tumor size in breast cancer. Arch Gynecol Obstet 291(6):1387–1394. doi:10.1007/s00404-014-3592-y CrossRefPubMed Schwab FD, Kilic N, Huang DJ, Schmid SM, Vetter M, Schötzau A, Güth U (2015) Personal or first-degree family breast cancer history: which has higher impact on tumor detection and tumor size in breast cancer. Arch Gynecol Obstet 291(6):1387–1394. doi:10.​1007/​s00404-014-3592-y CrossRefPubMed
32.
Zurück zum Zitat Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L, Tang J, Chen J, Wei K, Huang S, Wang J, Yu L, Zhao D (2014) Cancer survival in China, 2003–2005: a population-based study. Int J Cancer 136(8):1921–1930. doi:10.1002/ijc.29227 CrossRefPubMed Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L, Tang J, Chen J, Wei K, Huang S, Wang J, Yu L, Zhao D (2014) Cancer survival in China, 2003–2005: a population-based study. Int J Cancer 136(8):1921–1930. doi:10.​1002/​ijc.​29227 CrossRefPubMed
33.
Zurück zum Zitat Sivasubramaniam PG, Zhang BL, Zhang Q, Smith JS, Zhang B, Tang ZH, Chen GJ, Xie XM, Xu XZ, Yang HJ, He JJ, Li H, Li JY, Fan JH, Qiao YL (2015) Breast cancer disparities: a multicenter comparison of tumor diagnosis, characteristics, and surgical treatment in china and the US. Oncologist 20(9):1044–1050. doi:10.1634/theoncologist.2014-0290 CrossRefPubMedPubMedCentral Sivasubramaniam PG, Zhang BL, Zhang Q, Smith JS, Zhang B, Tang ZH, Chen GJ, Xie XM, Xu XZ, Yang HJ, He JJ, Li H, Li JY, Fan JH, Qiao YL (2015) Breast cancer disparities: a multicenter comparison of tumor diagnosis, characteristics, and surgical treatment in china and the US. Oncologist 20(9):1044–1050. doi:10.​1634/​theoncologist.​2014-0290 CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Jud SM, Hatko R, Maihöfner C, Bani MR, Schrauder MG, Lux MP, Beckmann MW, Bani G, Eder I, Fasching PA, Loehberg CR, Rauh C, Hein A (2014) Comprehensive visualization of paresthesia in breast cancer survivors. Arch Gynecol Obstet 290(1):135–141. doi:10.1007/s00404-014-3164-1 CrossRefPubMed Jud SM, Hatko R, Maihöfner C, Bani MR, Schrauder MG, Lux MP, Beckmann MW, Bani G, Eder I, Fasching PA, Loehberg CR, Rauh C, Hein A (2014) Comprehensive visualization of paresthesia in breast cancer survivors. Arch Gynecol Obstet 290(1):135–141. doi:10.​1007/​s00404-014-3164-1 CrossRefPubMed
35.
Zurück zum Zitat Yip CH, Cazap E, Anderson BO, Bright KL, Caleffi M, Cardoso F, Elzawawy AM, Harford JB, Krygier GD, Masood S, Murillo R, Muse IM, Otero IV, Passman LJ, Santini LA, da Silva RC, Thomas DB, Torres S, Zheng Y, Khaled HM (2011) Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast 20(Suppl 2):S12–S19. doi:10.1016/j.breast.2011.02.015 CrossRefPubMed Yip CH, Cazap E, Anderson BO, Bright KL, Caleffi M, Cardoso F, Elzawawy AM, Harford JB, Krygier GD, Masood S, Murillo R, Muse IM, Otero IV, Passman LJ, Santini LA, da Silva RC, Thomas DB, Torres S, Zheng Y, Khaled HM (2011) Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast 20(Suppl 2):S12–S19. doi:10.​1016/​j.​breast.​2011.​02.​015 CrossRefPubMed
36.
Zurück zum Zitat Committee of Breast Cancer Society, China Anti-Cancer Association (2011) China Anti-Cancer Association guidelines for breast cancer diagnosis and treatment. China Oncol 21 (in Chinese) Committee of Breast Cancer Society, China Anti-Cancer Association (2011) China Anti-Cancer Association guidelines for breast cancer diagnosis and treatment. China Oncol 21 (in Chinese)
38.
Zurück zum Zitat Kruk J (2014) Lifestyle components and primary breast cancer prevention. Asian Pac J Cancer Prev 15(24):10543–10555CrossRefPubMed Kruk J (2014) Lifestyle components and primary breast cancer prevention. Asian Pac J Cancer Prev 15(24):10543–10555CrossRefPubMed
Metadaten
Titel
Female breast cancer burden was increasing during the 40 years in Hebei Province, China: a population-based study
verfasst von
Jin Shi
Di Liang
Jing Jin
Liqun Wang
Yutong He
Publikationsdatum
12.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4149-z

Weitere Artikel der Ausgabe 5/2016

Archives of Gynecology and Obstetrics 5/2016 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.